Recursion Pharmaceuticals, Inc. (RXRX)
3.185
-0.14
(-4.35%)
USD |
NASDAQ |
Nov 13, 16:00
3.16
-0.02
(-0.78%)
After-Hours: 19:59
Recursion Pharmaceuticals Price to Book Value : 1.973 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.973 |
| November 12, 2026 | 2.063 |
| November 11, 2026 | 2.224 |
| November 10, 2026 | 2.199 |
| November 09, 2026 | 2.357 |
| November 06, 2026 | 2.180 |
| November 05, 2026 | 2.168 |
| November 04, 2026 | 2.403 |
| November 03, 2026 | 2.279 |
| November 02, 2026 | 2.372 |
| October 30, 2026 | 2.496 |
| October 29, 2026 | 2.626 |
| October 28, 2026 | 2.694 |
| October 27, 2026 | 2.509 |
| October 26, 2026 | 2.354 |
| October 23, 2026 | 2.292 |
| October 22, 2026 | 2.218 |
| October 21, 2026 | 2.255 |
| October 20, 2026 | 2.267 |
| October 19, 2026 | 2.236 |
| October 16, 2026 | 2.146 |
| October 15, 2026 | 2.577 |
| October 14, 2026 | 2.317 |
| October 13, 2026 | 2.375 |
| October 12, 2026 | 2.484 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.701 |
| October 08, 2026 | 2.447 |
| October 07, 2026 | 2.645 |
| October 06, 2026 | 2.868 |
| October 05, 2026 | 2.961 |
| October 02, 2026 | 2.552 |
| October 01, 2026 | 2.521 |
| September 30, 2026 | 2.558 |
| September 29, 2026 | 2.352 |
| September 28, 2026 | 2.160 |
| September 25, 2026 | 2.183 |
| September 24, 2026 | 2.271 |
| September 23, 2026 | 2.160 |
| September 22, 2026 | 2.364 |
| September 21, 2026 | 2.317 |
| September 18, 2026 | 2.236 |
| September 17, 2026 | 2.066 |
| September 16, 2026 | 1.862 |
| September 15, 2026 | 1.891 |
| September 14, 2026 | 1.990 |
| September 11, 2026 | 1.868 |
| September 10, 2026 | 1.845 |
| September 09, 2026 | 1.877 |
| September 08, 2026 | 2.008 |
| September 04, 2026 | 2.119 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Absci Corp. | 6.661 |
| Editas Medicine, Inc. | 3.945 |
| Twist Bioscience Corp. | 15.69 |
| Beam Therapeutics, Inc. | 2.479 |
| AbbVie, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 24.87 |
| Price | 3.185 |
| Earnings Yield | -28.02% |
| Market Cap | 1.787B |